North America Upstream Bioprocessing Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Upstream Bioprocessing Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Upstream Bioprocessing Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Upstream Bioprocessing Market Regional Analysis

6.2 North America Upstream Bioprocessing Market Revenue 2020-2030 (US$ Million)

6.3 North America Upstream Bioprocessing Market Forecast Analysis

7. North America Upstream Bioprocessing Market Analysis – by Product Type

7.1 Bioreactors/Fermenters

7.1.1 Overview
7.1.2 Bioreactors/Fermenters: North America Upstream Bioprocessing Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.2 Cell Culture

7.2.1 Overview
7.2.2 Cell Culture: North America Upstream Bioprocessing Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.3 Filters

7.3.1 Overview
7.3.2 Filters: North America Upstream Bioprocessing Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.4 Bags and Containers

7.4.1 Overview
7.4.2 Bags and Containers: North America Upstream Bioprocessing Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. North America Upstream Bioprocessing Market Analysis – by Workflow

8.1 Media Preparation

8.1.1 Overview
8.1.2 Media Preparation: North America Upstream Bioprocessing Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.2 Cell Culture

8.2.1 Overview
8.2.2 Cell Culture: North America Upstream Bioprocessing Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.3 Cell Separation

8.3.1 Overview
8.3.2 Cell Separation: North America Upstream Bioprocessing Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. North America Upstream Bioprocessing Market Analysis – by Mode

9.1 In-house

9.1.1 Overview
9.1.2 In-house: North America Upstream Bioprocessing Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.2 Outsourced

9.2.1 Overview
9.2.2 Outsourced : North America Upstream Bioprocessing Market – Revenue and Forecast, 2020-2030 (US$ Million)

10. North America Upstream Bioprocessing Market – North America Analysis

10.1 Overview

10.2 North America

10.2.1 North America Upstream Bioprocessing Market Breakdown, by Key Country, 2023 and 2030 (%)
10.2.1.1 North America Upstream Bioprocessing Market – Revenue and Forecast Analysis – by Country
10.2.1.1 US: North America Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.1.1 US: North America Upstream Bioprocessing Market Breakdown, by Product Type
10.2.1.1.2 US: North America Upstream Bioprocessing Market Breakdown, by Workflow
10.2.1.1.3 US: North America Upstream Bioprocessing Market Breakdown, by Mode

10.2.1.2 Canada: North America Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.2.1 Canada: North America Upstream Bioprocessing Market Breakdown, by Product Type
10.2.1.2.2 Canada: North America Upstream Bioprocessing Market Breakdown, by Workflow
10.2.1.2.3 Canada: North America Upstream Bioprocessing Market Breakdown, by Mode

10.2.1.3 Mexico : North America Upstream Bioprocessing Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.3.1 Mexico : North America Upstream Bioprocessing Market Breakdown, by Product Type
10.2.1.3.2 Mexico : North America Upstream Bioprocessing Market Breakdown, by Workflow
10.2.1.3.3 Mexico : North America Upstream Bioprocessing Market Breakdown, by Mode

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Thermo Fisher Scientific Inc

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Esco Micro Pte Ltd

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Sartorius AG

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Danaher Corp

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Getinge AB

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Merck KGaA

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Corning Inc

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Entegris Inc

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 PBS Biotech Inc-NA.

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

North America Upstream Bioprocessing Market

analysis - by Product Type (Bioreactors/Fermenters, Cell Culture, Filters, Bags and Containers, and Others), Workflow (Media Preparation, Cell Culture, and Cell Separation), Usage Type (Single-use and Multi-use), and Mode (In-house and Outsourced)